Optimization of near-infrared fluorescent sentinel lymph node mapping in cervical cancer patients

International Journal of Gynecological Cancer

Volumn 21, Issue 8, 2011, Pages 1472-1478

  Van Der Vorst, Joost R ^a   Hutteman, Merlijn ^a   Gaarenstroom, Katja N ^a   Peters, Alexander A W ^a   Mieog, J Sven D ^a   Schaafsma, Boudewijn E ^a   Kuppen, Peter J K ^a   Frangioni, John V ^b   Van De Velde, Cornelis J H ^a   Vahrmeijer, Alexander L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Cervical cancer; Image guided surgery; Indocyanine green; Near infrared fluorescence imaging; Sentinel lymph node mapping

Indexed keywords

HUMAN SERUM ALBUMIN; INDOCYANINE GREEN; COLORING AGENT; DIAGNOSTIC AGENT;

ADSORPTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); DOSIMETRY; FEMALE; FLUORESCENCE IMAGING; HUMAN; IMAGING SYSTEM; INTRAOPERATIVE PERIOD; NEAR INFRARED FLUORESCENCE IMAGING; PELVIS LYMPHADENECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE MAPPING; UTERINE CERVIX CANCER; FLUOROMETRY; LYMPH NODE; LYMPH NODE METASTASIS; MIDDLE AGED; PATHOLOGY; UTERINE CERVIX TUMOR;

ADULT; AGED; COLORING AGENTS; FEMALE; FLUOROMETRY; HUMANS; INDOCYANINE GREEN; INTRAOPERATIVE PERIOD; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; SENTINEL LYMPH NODE BIOPSY; UTERINE CERVICAL NEOPLASMS;

EID: 84856883938     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31822b451d     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-249.
2. Ferlay J, Bray F, Pisani P, et al. GLOBOCAN: Cancer Incidence, Mortality and Prevalence Worldwide. 1st ed. Lyon, France: IARCPress; 2001.
3. Hacker NF. Revised FIGO staging for carcinoma of the vulva. Int J Gynaecol Obstet. 2009;105:105-106.
4. Horn LC, Hentschel B, Fischer U, et al. Detection of micrometastases in pelvic lymph nodes in patients with carcinoma of the cervix uteri using step sectioning: frequency, topographic distribution and prognostic impact. Gynecol Oncol. 2008;111:276-281.
5. Green J, Kirwan J, Tierney J, et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev. 2005;CD002225.
6. Van Der Zee AG, Oonk MH, De Hullu JA, et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol. 2008;26:884-889. (Pubitemid 351398080)
7. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-399.
8. Levenback C, Coleman RL, Burke TW, et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol. 2002;20:688-693. (Pubitemid 34111375)
9. Marchiole P, Buenerd A, Scoazec JY, et al. Sentinel lymph node biopsy is not accurate in predicting lymph node status for patients with cervical carcinoma. Cancer. 2004;100:2154-2159. (Pubitemid 38580334)
10. Van de Lande J, Torrenga B, Raijmakers PG, et al. Sentinel lymph node detection in early stage uterine cervix carcinoma: a systematic review. Gynecol Oncol. 2007;106: 604-613. (Pubitemid 47302470)
11. Ercoli A, Delmas V, Iannone V, et al. The lymphatic drainage of the uterine cervix in adult fresh cadavers: anatomy and surgical implications. Eur J Surg Oncol. 2010;36:298-303.
12. Silva LB, Silva-Filho AL, Traiman P, et al. Sentinel node detection in cervical cancer with (99m)Tc-phytate. Gynecol Oncol. 2005;97:588-595. (Pubitemid 40614908)
13. Vahrmeijer AL, Frangioni JV. Seeing the invisible during surgery. Br J Surg. 2011;98:749-750.
14. Frangioni JV. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol. 2003;7:626-634. (Pubitemid 37315800)
15. Mieog JS, Troyan SL, Hutteman M, et al. Towards optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer. Ann Surg Oncol. 2011. [Epub ahead of print.]
16. Ohnishi S, Lomnes SJ, Laurence RG, et al. Organic alternatives to quantum dots for intraoperative near-infrared fluorescent sentinel lymph node mapping. Mol Imaging. 2005;4:172-181. (Pubitemid 43143790)
17. Crane LM, Themelis G, Pleijhuis RG, et al. Intraoperative multispectral fluorescence imaging for the detection of the sentinel lymph node in cervical cancer: a novel concept. Mol Imaging Biol. 2010.
18. Pieterse QD, Kenter GG, Gaarenstroom KN, et al. The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer. Eur J Surg Oncol. 2007;33:216-221. (Pubitemid 46349945)
19. Bader AA, Winter R, Haas J, et al. Where to look for the sentinel lymph node in cervical cancer. Am J Obstet Gynecol. 2007;197:678e1-678e7.
20. Steed H, Capstick V, Schepansky A, et al. Early cervical cancer and parametrial involvement: is it significant? Gynecol Oncol. 2006;103:53-57. (Pubitemid 44374668)
21. Winter R, Haas J, Reich O, et al. Parametrial spread of cervical cancer in patients with negative pelvic lymph nodes. Gynecol Oncol. 2002;84:252-257. (Pubitemid 34136776)
22. Photopulos GJ, Zwaag RV. Class II radical hysterectomy shows less morbidity and good treatment efficacy compared to class III. Gynecol Oncol. 1991;40:21-24.
23. Altgassen C, Hertel H, Brandstadt A, et al. Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO Study Group. J Clin Oncol. 2008;26:2943-2951.
24. Gioux S, Choi HS, Frangioni JV. Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation. Mol Imaging. 2010;9:237-255.
25. van der Poel HG, Buckle T, Brouwer OR, et al. Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer. Eur Urol. 2011. [Epub ahead of print.]